Lv21
140 积分 2024-09-10 加入
Results from VERONICA: A randomized, phase II study of second-/third-line venetoclax (VEN) + fulvestrant (F) versus F alone in estrogen receptor (ER)-positive, HER2-negative, locally advanced, or metastatic breast cancer (LA/MBC)
2小时前
已关闭
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma
19天前
已完结
Therapeutics targeting Bcl-2 in hematological malignancies
1个月前
已关闭
Precise RNA Editing: Cascade Self-Uncloaking Dual-Prodrug Nanoassemblies Based on CRISPR/Cas13a for Pleiotropic Immunotherapy of PD-L1-Resistant Colorectal Cancer
1个月前
已完结
Biomarker-guided therapy for colorectal cancer: strength in complexity
1个月前
已完结
Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
2个月前
已完结
New guise ADCs couple antibodies to degraders
2个月前
已完结
An intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer
2个月前
已完结
Exogenous Antigen Upregulation Empowers Antibody Targeted Nanochemotherapy of Leukemia
2个月前
已完结
皖公网安备34019202002308
